MedPath

Fluticasone Propionate

These highlights do not include all the information needed to use FLUTICASONE PROPIONATE nasal spray  safely and effectively. See full prescribing information for FLUTICASONE PROPIONATE nasal spray.FLUTICASONE PROPIONATE nasal spray, USP Initial U.S. Approval: 1994

Approved
Approval ID

4916301d-bcc8-4cd1-86b4-7bf0aecfbf68

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jun 14, 2023

Manufacturers
FDA

Preferred Pharmaceuticals, Inc.

DUNS: 791119022

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Fluticasone Propionate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68788-9678
Application NumberANDA077538
Product Classification
M
Marketing Category
C73584
G
Generic Name
Fluticasone Propionate
Product Specifications
Route of AdministrationNASAL
Effective DateJune 14, 2023
FDA Product Classification

INGREDIENTS (8)

MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
DEXTROSE, UNSPECIFIED FORMInactive
Code: IY9XDZ35W2
Classification: IACT
FLUTICASONE PROPIONATEActive
Quantity: 50 ug in 1 1
Code: O2GMZ0LF5W
Classification: ACTIB
BENZALKONIUM CHLORIDEInactive
Code: F5UM2KM3W7
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIEDInactive
Code: K679OBS311
Classification: IACT
POLYSORBATE 80Inactive
Code: 6OZP39ZG8H
Classification: IACT
PHENYLETHYL ALCOHOLInactive
Code: ML9LGA7468
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Fluticasone Propionate - FDA Drug Approval Details